DE3751527D1 - Zusammensetzungen zur Modulation der Effekten von TNF und IL-1. - Google Patents
Zusammensetzungen zur Modulation der Effekten von TNF und IL-1.Info
- Publication number
- DE3751527D1 DE3751527D1 DE3751527T DE3751527T DE3751527D1 DE 3751527 D1 DE3751527 D1 DE 3751527D1 DE 3751527 T DE3751527 T DE 3751527T DE 3751527 T DE3751527 T DE 3751527T DE 3751527 D1 DE3751527 D1 DE 3751527D1
- Authority
- DE
- Germany
- Prior art keywords
- tnf
- modulating
- compositions
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2006—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL80005A IL80005A (en) | 1986-09-10 | 1986-09-10 | Compositions for modulating the effect of tnf and il-1 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3751527D1 true DE3751527D1 (de) | 1995-10-26 |
DE3751527T2 DE3751527T2 (de) | 1996-02-22 |
Family
ID=11057124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3751527T Expired - Lifetime DE3751527T2 (de) | 1986-09-10 | 1987-09-09 | Zusammensetzungen zur Modulation der Effekten von TNF und IL-1. |
Country Status (9)
Country | Link |
---|---|
US (1) | US5211945A (de) |
EP (1) | EP0259863B1 (de) |
JP (1) | JPH07106986B2 (de) |
AU (1) | AU603134B2 (de) |
CA (1) | CA1322713C (de) |
DE (1) | DE3751527T2 (de) |
ES (1) | ES2080042T3 (de) |
IL (1) | IL80005A (de) |
ZA (1) | ZA876783B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1329119C (en) * | 1988-03-29 | 1994-05-03 | Milton David Goldenberg | Cytotoxic therapy |
US5120525A (en) * | 1988-03-29 | 1992-06-09 | Immunomedics, Inc. | Radiolabeled antibody cytotoxic therapy of cancer |
EP0393438B1 (de) * | 1989-04-21 | 2005-02-16 | Amgen Inc. | TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs |
US7264944B1 (en) | 1989-04-21 | 2007-09-04 | Amgen Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
US6221675B1 (en) | 1989-04-21 | 2001-04-24 | Amgen, Inc. | TNF receptors, TNF binding proteins and DNAs coding for them |
US6143866A (en) * | 1989-07-18 | 2000-11-07 | Amgen, Inc. | Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
IL95031A (en) | 1989-07-18 | 2007-03-08 | Amgen Inc | A method of producing a recombinant human necrotic factor absorber |
US6541610B1 (en) * | 1989-09-05 | 2003-04-01 | Immunex Corporation | Fusion proteins comprising tumor necrosis factor receptor |
DE59010933D1 (de) | 1989-09-12 | 2003-05-08 | Hoffmann La Roche | TFN-bindende Proteine |
US5370870A (en) * | 1989-10-06 | 1994-12-06 | Genentech, Inc. | Method for protection against reactive oxygen species |
US5200176A (en) * | 1989-10-06 | 1993-04-06 | Genentech, Inc. | Method for protection of ischemic tissues using tumor nerosis factor |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
IL97779A (en) * | 1990-04-10 | 2000-01-31 | Genentech Inc | Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof |
US20030064480A1 (en) * | 1990-06-28 | 2003-04-03 | Leander Lauffer | Fusion proteins with immunoglobulin portions, the preparation and use thereof |
EP0495131B1 (de) * | 1990-08-10 | 1997-05-14 | Otsuka Pharmaceutical Co., Ltd. | Wirkstoff zur hepatitisverhütung und -behandlung |
US6685930B1 (en) * | 1991-03-27 | 2004-02-03 | Tanox, Inc. | Methods and substances for recruiting therapeutic agents to solid tumors |
AU671116B2 (en) * | 1992-03-30 | 1996-08-15 | Immunex Corporation | Fusion proteins comprising tumor necrosis factor receptor |
US5632982A (en) * | 1994-06-07 | 1997-05-27 | The Board Of Trustees Of The Leland Stanford Junior University | Cytotoxic enhancement of TNF with copper |
TW555765B (en) | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
ES2207759T3 (es) | 1996-12-06 | 2004-06-01 | Amgen Inc. | Terapia de combinacion que utiliza una proteina de union del factor de necrosis tumoral (tnf) en el tratamiento de enfermedades inducidas por el tnf. |
US6287558B1 (en) | 1997-08-01 | 2001-09-11 | Biohybrio Technologies Llc | Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
AU1623300A (en) * | 1998-11-13 | 2000-06-05 | Sensor Technologies, Inc. | Monodisperse preparations useful with implanted devices |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1265444A (en) * | 1983-06-27 | 1990-02-06 | Lloyd J. Old | Effect of human tumor necrosis factor and human interferon on human cancer cells and methods |
DE3423234A1 (de) * | 1984-06-23 | 1986-02-06 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Synergistische mischungen von interferonen und tumor-nekrose-faktor |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
US4863727A (en) * | 1986-04-09 | 1989-09-05 | Cetus Corporation | Combination therapy using interleukin-2 and tumor necrosis factor |
CA1290249C (en) * | 1986-04-09 | 1991-10-08 | Cetus Corporation | COMBINATION THERAPY USING INTERLEUKIN-2 AND/OR INTERFERON-.beta. AND TUMOR NECROSIS FACTOR |
US4879111A (en) * | 1986-04-17 | 1989-11-07 | Cetus Corporation | Treatment of infections with lymphokines |
US4980160A (en) * | 1986-10-16 | 1990-12-25 | Biogen, Inc. | Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases |
US4816436A (en) * | 1986-10-29 | 1989-03-28 | Immunex Corporation | Anti-arthritic use of interleukin-1 proteins |
JPH07106158B2 (ja) * | 1986-12-04 | 1995-11-15 | サントリー株式会社 | 抗腫瘍活性を有する新規ポリペプチドおよびその製造法 |
-
1986
- 1986-09-10 IL IL80005A patent/IL80005A/xx not_active IP Right Cessation
-
1987
- 1987-09-09 DE DE3751527T patent/DE3751527T2/de not_active Expired - Lifetime
- 1987-09-09 EP EP87113198A patent/EP0259863B1/de not_active Expired - Lifetime
- 1987-09-09 US US07/094,981 patent/US5211945A/en not_active Expired - Lifetime
- 1987-09-09 AU AU78205/87A patent/AU603134B2/en not_active Expired
- 1987-09-09 ES ES87113198T patent/ES2080042T3/es not_active Expired - Lifetime
- 1987-09-09 CA CA000546472A patent/CA1322713C/en not_active Expired - Lifetime
- 1987-09-10 ZA ZA876783A patent/ZA876783B/xx unknown
- 1987-09-10 JP JP62227521A patent/JPH07106986B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0259863B1 (de) | 1995-09-20 |
EP0259863A3 (en) | 1989-11-02 |
JPS63146830A (ja) | 1988-06-18 |
AU603134B2 (en) | 1990-11-08 |
IL80005A (en) | 1992-11-15 |
US5211945A (en) | 1993-05-18 |
ES2080042T3 (es) | 1996-02-01 |
EP0259863A2 (de) | 1988-03-16 |
AU7820587A (en) | 1988-03-17 |
JPH07106986B2 (ja) | 1995-11-15 |
CA1322713C (en) | 1993-10-05 |
ZA876783B (en) | 1988-05-25 |
IL80005A0 (en) | 1986-12-31 |
DE3751527T2 (de) | 1996-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3751527D1 (de) | Zusammensetzungen zur Modulation der Effekten von TNF und IL-1. | |
DE68925975D1 (de) | Zusammensetzung zur Verhinderung der übertragung von AIDS. | |
DE3581953D1 (de) | Smektische fluessigkristallverbindung und fluessigkristallzusammensetzungen. | |
DE68922049D1 (de) | Pulsbreiten-modulierte Leistungsversorgung mit Unterdrückungsfähigkeit von Modulierungsfrequenzsignalkomponenten von Erdpotentialen. | |
DE3674642D1 (de) | Zur modifizierung von bitumen verwendbare polymerzusammensetzungen und so modifizierte bitumenmassen. | |
DE3866658D1 (de) | Zementzusammensetzungen auf basis von aluminiumphosphat und diese enthaltende lampenverbindungen. | |
DE3667605D1 (de) | Windel zur verhuetung von wundliegen. | |
DE3687920D1 (de) | Elektrooptischer welleneleitermodulator. | |
DE3680507D1 (de) | Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie. | |
DE3672143D1 (de) | Koernige zusammensetzungen von fluorelastomeren. | |
DE3777878D1 (de) | Mittel zur verhinderung des zusammenbackens von duengemitteln. | |
FR2554933B1 (fr) | Modulateur et/ou deflecteur acoustico-optique | |
DE3579845D1 (de) | Fluessigkristall-verbindung und dieselbe enthaltende fluessigkristallzusammensetzung. | |
ATE79255T1 (de) | Wirkstoffe zur verhuetung von tumormetastasen. | |
DD129729A5 (de) | Mittel zur wachstumsverzoegerung und zur entblaetterung von pflanzen | |
DE3778104D1 (de) | Zusammenstellung von hydroxylapatite-teilchen und diese enthaltende fluessigkeitschromatographie-saeule. | |
DE3766153D1 (de) | Vorbeugung der geruchsabschwaechung von mit organoschwefelverbindungen odorisiertem fluessiggas. | |
DE3688448D1 (de) | Elimination von feldinduzierten instabilitaeten in elektrooptischen modulatoren. | |
DE3682155D1 (de) | Fluessigkristall-alkoxycarbonyloxybenzoesaeurederivate und zusammensetzung. | |
DE3670757D1 (de) | Zusammensetzung zur erhoehung der quantitaet und der qualitaet von pflanzenfruechten und -blueten. | |
ATA196785A (de) | Einrichtung zur nutzung von ueberschussdampf | |
ATA311386A (de) | Einrichtung zur kompensation der hochschlagund rueckstossenergie von faustfeuerwaffen | |
DD280029A1 (de) | Mittel zur erhoehung der stresstoleranz von kulturpflanzen | |
DE3672039D1 (de) | Einrichtung zur filtrierung und transienten stabilisierung der netzspannung. | |
DD136162A1 (de) | Seitenablauf zur entwaesserung von verkehrsflaechen und dergleichen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |